News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,015 Results
Type
Article (25936)
Company Profile (59)
Press Release (356020)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104279)
Career Advice (449)
Deals (16877)
Drug Delivery (51)
Drug Development (47670)
Employer Resources (47)
FDA (12266)
Job Trends (8445)
News (186025)
Policy (19427)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (73)
Alliances (26755)
ALS (57)
Alzheimer's disease (813)
Antibody-drug conjugate (ADC) (52)
Approvals (12329)
Artificial intelligence (170)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6897)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (193)
Cancer (1441)
Cardiovascular disease (119)
Career advice (407)
Career pathing (13)
CAR-T (71)
Cell therapy (202)
Cervical cancer (13)
Clinical research (40598)
Collaboration (444)
Compensation (130)
Complete response letters (9)
COVID-19 (1493)
CRISPR (12)
C-suite (141)
Cystic fibrosis (42)
Data (1544)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (176)
Diagnostics (3522)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (55)
Earnings (36952)
Editorial (20)
Employer branding (6)
Employer resources (44)
Events (51865)
Executive appointments (451)
FDA (13267)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (405)
Gene editing (37)
Generative AI (10)
Gene therapy (128)
GLP-1 (403)
Government (3035)
Grass and pollen (3)
Guidances (51)
Healthcare (12190)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (40)
Indications (19)
Infectious disease (1563)
Inflammatory bowel disease (80)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (50)
Interviews (40)
IPO (7042)
IRA (19)
Job creations (1839)
Job search strategy (378)
Kidney cancer (7)
Labor market (10)
Layoffs (170)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (232)
Lymphoma (101)
Machine learning (3)
Management (17)
Manufacturing (104)
MASH (49)
Medical device (12908)
Medtech (12911)
Mergers & acquisitions (10129)
Metabolic disorders (436)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1146)
NextGen: Class of 2025 (3931)
Non-profit (2825)
Now hiring (16)
Obesity (219)
Opinion (70)
Ovarian cancer (52)
Pain (66)
Pancreatic cancer (55)
Parkinson's disease (88)
Partnered (11)
Patents (114)
Patient recruitment (82)
Peanut (37)
People (34725)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11622)
Phase II (17569)
Phase III (14449)
Pipeline (699)
Policy (60)
Postmarket research (1672)
Preclinical (3619)
Press Release (18)
Prostate cancer (77)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (183)
Real estate (2846)
Recruiting (16)
Regulatory (14219)
Reports (16)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (51)
Series A (67)
Series B (49)
Service/supplier (3)
Sickle cell disease (21)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2120)
Stomach cancer (8)
Supply chain (38)
Tariffs (12)
The Weekly (8)
Vaccines (354)
Venture capitalists (13)
Weight loss (141)
Women's health (17)
Worklife (4)
Date
Today (88)
Last 7 days (402)
Last 30 days (1421)
Last 365 days (18500)
2025 (6010)
2024 (19874)
2023 (22757)
2022 (30692)
2021 (32998)
2020 (32202)
2019 (28427)
2018 (21819)
2017 (18917)
2016 (18118)
2015 (21201)
2014 (16033)
2013 (13249)
2012 (14356)
2011 (14629)
2010 (13190)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (118)
Arkansas (10)
Asia (24581)
Australia (3894)
California (3079)
Canada (1229)
China (374)
Colorado (165)
Connecticut (172)
Delaware (117)
Europe (47977)
Florida (547)
Georgia (126)
Idaho (33)
Illinois (360)
India (14)
Indiana (226)
Iowa (3)
Japan (121)
Kansas (73)
Kentucky (13)
Louisiana (7)
Maine (27)
Maryland (635)
Massachusetts (2146)
Michigan (108)
Minnesota (273)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (33)
New Hampshire (60)
New Jersey (1134)
New Mexico (9)
New York (963)
North Carolina (556)
North Dakota (4)
Northern California (1343)
Ohio (131)
Oklahoma (3)
Oregon (23)
Pennsylvania (830)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (21)
Southern California (1186)
Tennessee (77)
Texas (544)
United States (12866)
Utah (112)
Virginia (81)
Washington D.C. (41)
Washington State (229)
West Virginia (3)
Wisconsin (44)
382,015 Results for "qol medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients’ Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
February 19, 2025
·
5 min read
FDA
QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with Congenital Sucrase-Isomaltase Deficiency (CSID)
QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, announced today that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid® single-use containers for patients more than 33 lb (15 kg) with Congenital Sucrase-Isomaltase Deficiency (CSID).
September 6, 2022
·
3 min read
Business
QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Best Support Congenital Sucrase-Isomaltase Deficiency (CSID) Patients on Sucraid® (sacrosidase) Oral Solution
QOL Medical, LLC announced today it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution.
April 15, 2022
·
4 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
Genetown
Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD/PD™ 2023 Annual Meeting
Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented new analyses on amyloid-related imaging abnormalities with the use of antiplatelet and anticoagulant medications, isolated ARIA-H, and caregiver burden and health-related quality of life, from the results of Eisai’s Phase 3 Clarity AD study of lecanemab, an anti-amyloid-β protofibril* antibody, at the 2023 International Conference on Alzheimer’s and Parkinson’s Diseases annual meeting AD/PD™.
March 30, 2023
·
13 min read
Press Releases
Neuspera Medical Announces Landmark Six-Month Clinical Trial Results for the First Battery-Free Percutaneous Sacral Neuromodulation (pSNM) System for Urgency Urinary Incontinence Management
February 27, 2025
·
5 min read
Press Releases
Trial Finds Inquis Medical’s AVENTUS Thrombectomy System Safe and Effective for Patients with Pulmonary Embolism
May 2, 2025
·
4 min read
Press Releases
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
January 9, 2025
·
2 min read
Press Releases
AVITA Medical to Announce First Quarter 2025 Financial Results
April 17, 2025
·
1 min read
1 of 38,202
Next
